Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
6.73
+0.06 (0.90%)
Mar 10, 2026, 3:00 PM HKT
HKG:0719 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 10,048 | 9,282 | 11,897 | 17,740 | 6,846 | 5,447 | Upgrade
|
| Market Cap Growth | 7.96% | -21.98% | -32.94% | 159.15% | 25.67% | 25.64% | Upgrade
|
| Enterprise Value | 10,626 | 10,083 | 12,706 | 17,708 | 8,175 | 6,459 | Upgrade
|
| Last Close Price | 6.67 | 5.57 | 5.23 | 7.09 | 3.95 | 2.88 | Upgrade
|
| PE Ratio | 11.10 | 18.56 | 21.75 | 38.17 | 16.00 | 14.12 | Upgrade
|
| PS Ratio | 1.08 | 1.03 | 1.33 | 2.09 | 0.85 | 0.76 | Upgrade
|
| PB Ratio | 1.71 | 1.67 | 2.26 | 3.61 | 1.53 | 1.35 | Upgrade
|
| P/TBV Ratio | 2.00 | 1.97 | 2.66 | 4.30 | 1.86 | 1.65 | Upgrade
|
| P/FCF Ratio | 34.18 | 56.20 | - | 30.56 | 563.90 | 32.76 | Upgrade
|
| P/OCF Ratio | 21.12 | 23.73 | 40.71 | 20.70 | 21.52 | 10.92 | Upgrade
|
| EV/Sales Ratio | 1.14 | 1.12 | 1.42 | 2.09 | 1.01 | 0.91 | Upgrade
|
| EV/EBITDA Ratio | 9.74 | 9.03 | 11.24 | 16.45 | 7.93 | 6.45 | Upgrade
|
| EV/EBIT Ratio | 22.17 | 18.56 | 22.52 | 33.62 | 16.50 | 11.86 | Upgrade
|
| EV/FCF Ratio | 36.15 | 61.05 | - | 30.51 | 673.39 | 38.85 | Upgrade
|
| Debt / Equity Ratio | 0.28 | 0.32 | 0.28 | 0.32 | 0.45 | 0.49 | Upgrade
|
| Debt / EBITDA Ratio | 1.52 | 1.58 | 1.32 | 1.45 | 1.95 | 1.95 | Upgrade
|
| Debt / FCF Ratio | 5.66 | 10.74 | - | 2.70 | 166.46 | 11.75 | Upgrade
|
| Net Debt / Equity Ratio | 0.05 | 0.08 | 0.09 | 0.05 | 0.25 | 0.23 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.29 | 0.40 | 0.43 | 0.24 | 1.07 | 0.94 | Upgrade
|
| Net Debt / FCF Ratio | 1.07 | 2.72 | -7.36 | 0.44 | 91.16 | 5.64 | Upgrade
|
| Asset Turnover | 0.95 | 0.98 | 0.98 | 0.96 | 0.91 | 0.89 | Upgrade
|
| Inventory Turnover | 5.40 | 5.01 | 4.58 | 4.93 | 4.48 | 3.77 | Upgrade
|
| Quick Ratio | 0.85 | 0.85 | 0.76 | 0.68 | 0.65 | 0.59 | Upgrade
|
| Current Ratio | 1.31 | 1.33 | 1.33 | 1.09 | 1.10 | 1.13 | Upgrade
|
| Return on Equity (ROE) | 7.59% | 9.74% | 11.09% | 10.65% | 10.28% | 10.68% | Upgrade
|
| Return on Assets (ROA) | 3.06% | 3.69% | 3.87% | 3.73% | 3.50% | 4.24% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.97% | 8.58% | 9.94% | 9.22% | 7.95% | 9.52% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.20% | 8.20% | 8.80% | 9.10% | 8.40% | 9.70% | Upgrade
|
| Earnings Yield | 4.16% | 5.39% | 4.60% | 2.62% | 6.25% | 7.08% | Upgrade
|
| FCF Yield | 2.93% | 1.78% | -0.55% | 3.27% | 0.18% | 3.05% | Upgrade
|
| Dividend Yield | 4.46% | 5.26% | 5.27% | 3.19% | 4.66% | 6.19% | Upgrade
|
| Payout Ratio | 55.78% | 48.05% | 35.43% | 39.66% | 42.59% | 39.05% | Upgrade
|
| Buyback Yield / Dilution | 0.13% | 0.54% | -3.20% | -6.93% | 0.02% | -0.86% | Upgrade
|
| Total Shareholder Return | 4.59% | 5.80% | 2.07% | -3.74% | 4.68% | 5.33% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.